10-Q Filing

LifeMD, Inc. CIK: 948320 Q1 2017

Filing Information

Form Type	10-Q
Accession Number	`0001213900-17-007275`
Period End Date	20170331
Filing Date	20170707
Fiscal Year	2017
Fiscal Period	Q1
XBRL Instance	immd-20170331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 51 Income Statement 34 Cash Flow Statement 58 Stockholders Equity 18

Balance Sheet 51 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$232.98K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	40.54M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	217,391.00	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$381.06K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	35.57M	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$182.56K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$203.62K	USD	Point-in-time
Trade accounts receivable, net	`AccountsReceivableNetCurrent`	$555.71K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	40.21M	shares	Point-in-time
Trade accounts receivable, net	`AccountsReceivableNetCurrent`	$444.74K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	35.25M	shares	Point-in-time
Treasury stock, common, shares	`TreasuryStockCommonShares`	337,800.00	shares	Point-in-time
Treasury stock, common, shares	`TreasuryStockCommonShares`	325,000.00	shares	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	-	USD	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$2.25K	USD	Point-in-time
Inventory, net	`InventoryNet`	$160.27K	USD	Point-in-time
Inventory, net	`InventoryNet`	$136.94K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$1.07M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$789.82K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$752.93K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$562.22K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$192.25K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$1.81M	USD	Point-in-time
Convertible notes payable	`ConvertibleNotesPayableCurrent`	$100.00K	USD	Point-in-time
Convertible notes payable	`ConvertibleNotesPayableCurrent`	-	USD	Point-in-time
Notes payable, net of discount	`NotesPayableCurrent`	$25.00K	USD	Point-in-time
Notes payable, net of discount	`NotesPayableCurrent`	$106.36K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$1.15M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$2.40M	USD	Point-in-time
Common stock, $0.01 par value; 50,000,000 shares authorized, 40,543,373 and 35,570,157 shares issued, 40,205,573 and 35,245,157 outstanding as of March 31, 2017 and December 31, 2016, respectively	`CommonStockValue`	$355.70K	USD	Point-in-time
Common stock, $0.01 par value; 50,000,000 shares authorized, 40,543,373 and 35,570,157 shares issued, 40,205,573 and 35,245,157 outstanding as of March 31, 2017 and December 31, 2016, respectively	`CommonStockValue`	$405.43K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$9.36M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$9.07M	USD	Point-in-time
Accumulated (deficit)	`RetainedEarningsAccumulatedDeficit`	$-10.74M	USD	Point-in-time
Accumulated (deficit)	`RetainedEarningsAccumulatedDeficit`	$-9.69M	USD	Point-in-time
Equity	`Equity`	$-268.12K	USD	Point-in-time
Equity	`Equity`	$-970.09K	USD	Point-in-time
Treasury stock, 337,800 and 325,000 shares, at cost	`TreasuryStockValue`	$90.20K	USD	Point-in-time
Treasury stock, 337,800 and 325,000 shares, at cost	`TreasuryStockValue`	$87.05K	USD	Point-in-time
Total Immudyne, Inc. Stockholders' (Deficit)	`StockholdersEquity`	$-355.17K	USD	Point-in-time
Total Immudyne, Inc. Stockholders' (Deficit)	`StockholdersEquity`	$-1.06M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$-263.11K	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$-6.55K	USD	Point-in-time
Total Stockholders' (Deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-361.73K	USD	Point-in-time
Total Stockholders' (Deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.32M	USD	Point-in-time
Total Liabilities and Stockholders' (Deficit)	`LiabilitiesAndStockholdersEquity`	$789.82K	USD	Point-in-time
Total Liabilities and Stockholders' (Deficit)	`LiabilitiesAndStockholdersEquity`	$1.07M	USD	Point-in-time

Income Statement 34 line items

Line Item	Tag	Value	Unit	Period
Net Sales	`Revenues`	$1.64M	USD	1 Quarter
Net Sales	`Revenues`	$424.46K	USD	1 Quarter
Cost of Sales	`CostOfRevenue`	$1.34M	USD	1 Quarter
Cost of Sales	`CostOfRevenue`	$203.36K	USD	1 Quarter
Gross Profit	`GrossProfit`	$221.11K	USD	1 Quarter
Gross Profit	`GrossProfit`	$303.09K	USD	1 Quarter
Compensation and related expenses	`CompensationAndRelatedExpenses`	$240.46K	USD	1 Quarter
Compensation and related expenses	`CompensationAndRelatedExpenses`	$358.49K	USD	1 Quarter
Professional fees	`ProfessionalFees`	$69.31K	USD	1 Quarter
Professional fees	`ProfessionalFees`	$99.63K	USD	1 Quarter
Marketing expenses	`MarketingExpense`	-	USD	1 Quarter
Marketing expenses	`MarketingExpense`	$10.80K	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$127.17K	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$98.41K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$408.18K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$596.09K	USD	1 Quarter
Operating (Loss)	`OperatingIncomeLoss`	$-374.99K	USD	1 Quarter
Operating (Loss)	`OperatingIncomeLoss`	$-105.10K	USD	1 Quarter
Change in fair value of derivative liability	`ChangeInFairValueOfDerivativeLiability`	$48.19K	USD	1 Quarter
Change in fair value of derivative liability	`ChangeInFairValueOfDerivativeLiability`	-	USD	1 Quarter
Interest (expense)	`InterestExpense`	$649.36K	USD	1 Quarter
Interest (expense)	`InterestExpense`	$3.06K	USD	1 Quarter
Net (Loss)	`ProfitLoss`	$-108.16K	USD	1 Quarter
Net (Loss)	`ProfitLoss`	$-1.07M	USD	1 Quarter
Net (loss) attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-46.11K	USD	1 Quarter
Net (loss) attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-27.73K	USD	1 Quarter
Net (loss) attributable to Immudyne, Inc.	`NetIncomeLoss`	$-62.05K	USD	1 Quarter
Net (loss) attributable to Immudyne, Inc.	`NetIncomeLoss`	$-1.04M	USD	1 Quarter
Basic and diluted (loss) per share attributable to Immudyne, Inc.	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
Basic and diluted (loss) per share attributable to Immudyne, Inc.	`EarningsPerShareBasicAndDiluted`	$-0.03	USD	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	37.58M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	32.01M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	37.58M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	32.01M	shares	1 Quarter

Cash Flow Statement 58 line items

Line Item	Tag	Value	Unit	Period
Net (loss) attributable to Immudyne, Inc.	`NetIncomeLoss`	$-62.05K	USD	1 Quarter
Net (loss) attributable to Immudyne, Inc.	`NetIncomeLoss`	$-1.04M	USD	1 Quarter
Net (loss) attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-46.11K	USD	1 Quarter
Net (loss) attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-27.73K	USD	1 Quarter
Net (loss)	`ProfitLoss`	$-108.16K	USD	1 Quarter
Net (loss)	`ProfitLoss`	$-1.07M	USD	1 Quarter
Change in fair value of derivative liability	`IncreaseDecreaseInDerivativeLiabilities`	$48.19K	USD	1 Quarter
Change in fair value of derivative liability	`IncreaseDecreaseInDerivativeLiabilities`	-	USD	1 Quarter
Bad debt recovery	`ProvisionForDoubtfulAccounts`	$-38.03K	USD	1 Quarter
Bad debt recovery	`ProvisionForDoubtfulAccounts`	-	USD	1 Quarter
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	-	USD	1 Quarter
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$81.56K	USD	1 Quarter
Loss on settlement of notes payable	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on settlement of notes payable	`GainsLossesOnExtinguishmentOfDebt`	$-553.22K	USD	1 Quarter
Stock compensation expense	`ShareBasedCompensation`	$190.19K	USD	1 Quarter
Stock compensation expense	`ShareBasedCompensation`	$38.87K	USD	1 Quarter
Trade accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$144.90K	USD	1 Quarter
Trade accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$72.94K	USD	1 Quarter
Other receivables	`IncreaseDecreaseInOtherReceivables`	-	USD	1 Quarter
Other receivables	`IncreaseDecreaseInOtherReceivables`	$-2.25K	USD	1 Quarter
Inventory	`IncreaseDecreaseInInventories`	$77.44K	USD	1 Quarter
Inventory	`IncreaseDecreaseInInventories`	$-23.33K	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-188.50K	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$169.48K	USD	1 Quarter
Net cash (used) by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-473.26K	USD	1 Quarter
Net cash (used) by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-122.16K	USD	1 Quarter
Investment in subsidiary by noncontrolling interest, net	`ProceedsFromPaymentsToMinorityShareholders`	$43.38K	USD	1 Quarter
Investment in subsidiary by noncontrolling interest, net	`ProceedsFromPaymentsToMinorityShareholders`	$92.79K	USD	1 Quarter
Proceeds from notes payable	`ProceedsFromNotesPayable`	$235.00K	USD	1 Quarter
Proceeds from notes payable	`ProceedsFromNotesPayable`	-	USD	1 Quarter
Repayment of convertible note payable	`RepaymentsOfConvertibleDebt`	-	USD	1 Quarter
Repayment of convertible note payable	`RepaymentsOfConvertibleDebt`	$100.00K	USD	1 Quarter
Repayment of notes payable	`RepaymentsOfNotesPayable`	$151.42K	USD	1 Quarter
Repayment of notes payable	`RepaymentsOfNotesPayable`	-	USD	1 Quarter
Sale of common stock and warrants	`IssuanceOfCommonStockAndWarrants`	$647.94K	USD	1 Quarter
Sale of common stock and warrants	`IssuanceOfCommonStockAndWarrants`	-	USD	1 Quarter
Purchase of treasury stock	`ProceedsFromIssuanceOfCommonStock`	$-3.15K	USD	1 Quarter
Purchase of treasury stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$92.79K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$671.75K	USD	1 Quarter
Net increase (decrease) in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-29.36K	USD	1 Quarter
Net increase (decrease) in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$198.50K	USD	1 Quarter
Cash at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$232.98K	USD	Point-in-time
Cash at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$381.06K	USD	Point-in-time
Cash at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$182.56K	USD	Point-in-time
Cash at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$203.62K	USD	Point-in-time
Cash at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$232.98K	USD	Point-in-time
Cash at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$381.06K	USD	Point-in-time
Cash at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$182.56K	USD	Point-in-time
Cash at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$203.62K	USD	Point-in-time
Cash paid during the period for interest	`InterestPaid`	$3.06K	USD	1 Quarter
Cash paid during the period for interest	`InterestPaid`	$3.61K	USD	1 Quarter
Issuance of company stock for notes and other payables	`ConversionOfStockAmountIssued1`	$192.19K	USD	1 Quarter
Issuance of company stock for notes and other payables	`ConversionOfStockAmountIssued1`	-	USD	1 Quarter
Conversion of equity invested in subsidiary to common stock and warrants	`ConversionOfEquityInvestedInSubsidiaryToCommonStockAndWarrants`	-	USD	1 Quarter
Conversion of equity invested in subsidiary to common stock and warrants	`ConversionOfEquityInvestedInSubsidiaryToCommonStockAndWarrants`	$272.20K	USD	1 Quarter
Reclassification of options, warrants and other contracts to derivative liabilities upon issuance	`ReclassificationOfOptionsWarrantsAndOtherContractsToDerivativeLiabilities`	-	USD	1 Quarter
Reclassification of options, warrants and other contracts to derivative liabilities upon issuance	`ReclassificationOfOptionsWarrantsAndOtherContractsToDerivativeLiabilities`	$1.57M	USD	1 Quarter

Stockholders Equity 18 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-361.73K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.32M	USD	Point-in-time
Issuance of common stock for services	`StockIssuedDuringPeriodValueIssuedForServices`	$76.67K	USD	1 Quarter
Sale of common stock and warrants	`StockIssuedDuringPeriodValueNewIssues`	$647.94K	USD	1 Quarter
Conversion of non-controlling interest equity for shares and warrants	`StockIssuedDuringPeriodValueConversionOfUnits`	-	USD	1 Quarter
Conversion of note payable	`StockIssuedDuringPeriodValueOther`	$745.41K	USD	1 Quarter
Issuance of common stock in relation to debt offering	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$56.52K	USD	1 Quarter
Issuance of common stock in relation to debt offering	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$58.75K	USD	Point-in-time
Issuance of common stock in relation to debt offering, shares	`StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities`	62,500.00	shares	1 Quarter
Issuance of common stock in relation to debt offering, shares	`StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities`	250,000.00	shares	Point-in-time
Purchase of treasury stock	`TreasuryStockValueAcquiredCostMethod`	$-3.15K	USD	1 Quarter
Issuance of stock options for services	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$113.52K	USD	1 Quarter
Investment in subsidiary by noncontrolling interest, net of distributions	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$43.38K	USD	1 Quarter
Reclassification of options, warrants and other contracts to derivative liabilities upon issuance	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationReclassificationOfOptionsWarrantsAndOtherContractsFromEquityToDerivativeLiabilities`	$-1.57M	USD	1 Quarter
Net (loss)	`ProfitLoss`	$-108.16K	USD	1 Quarter
Net (loss)	`ProfitLoss`	$-1.07M	USD	1 Quarter
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-361.73K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.32M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.